A detailed history of Lgt Group Foundation transactions in Medtronic PLC stock. As of the latest transaction made, Lgt Group Foundation holds 80,303 shares of MDT stock, worth $7.03 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
80,303
Previous 76,919 4.4%
Holding current value
$7.03 Million
Previous $6.05 Million 19.41%
% of portfolio
0.12%
Previous 0.09%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$76.84 - $91.03 $260,026 - $308,045
3,384 Added 4.4%
80,303 $7.23 Million
Q2 2024

Aug 07, 2024

BUY
$78.71 - $87.02 $3,856 - $4,263
49 Added 0.06%
76,919 $6.05 Million
Q1 2024

May 14, 2024

SELL
$82.84 - $88.09 $2.82 Million - $3 Million
-34,003 Reduced 30.67%
76,870 $6.7 Million
Q4 2023

Feb 06, 2024

SELL
$69.43 - $83.43 $8.3 Million - $9.97 Million
-119,514 Reduced 51.88%
110,873 $9.13 Million
Q3 2023

Nov 06, 2023

BUY
$78.22 - $90.4 $257,656 - $297,777
3,294 Added 1.45%
230,387 $18.1 Million
Q2 2023

Jul 27, 2023

SELL
$79.47 - $91.38 $5.75 Million - $6.61 Million
-72,339 Reduced 24.16%
227,093 $20 Million
Q1 2023

Apr 20, 2023

BUY
$76.72 - $87.58 $534,584 - $610,257
6,968 Added 2.38%
299,432 $24.1 Million
Q4 2022

Feb 09, 2023

BUY
$76.18 - $87.74 $4.93 Million - $5.68 Million
64,759 Added 28.44%
292,464 $22.7 Million
Q3 2022

Oct 19, 2022

SELL
$80.75 - $95.31 $6.7 Million - $7.91 Million
-82,971 Reduced 26.71%
227,705 $18.4 Million
Q2 2022

Aug 03, 2022

BUY
$87.4 - $113.09 $4.48 Million - $5.79 Million
51,208 Added 19.74%
310,676 $27.9 Million
Q1 2022

May 11, 2022

BUY
$100.58 - $112.38 $6.27 Million - $7.01 Million
62,350 Added 31.63%
259,468 $29.2 Million
Q4 2021

May 03, 2022

BUY
$99.53 - $127.75 $19.6 Million - $25.2 Million
197,118 New
197,118 $20.4 Million

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $116B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Lgt Group Foundation Portfolio

Follow Lgt Group Foundation and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lgt Group Foundation, based on Form 13F filings with the SEC.

News

Stay updated on Lgt Group Foundation with notifications on news.